MAPK3 and breast cancer: During the research on IMD, we have found that IMD can activate ERK1/2 by inducing Src phosphorylation in more than 20 kinds of cells (including tumor cells such as liver cancer cells, breast cancer cells, glioma cells; and normal cells such as endothelial cells, fibroblasts, smooth muscle cells, etc.).